Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial)|
Van Baaren, G.
Van Lith, J.
Nij Bijvank, S.
Van Eyck, J.
|Citation:||American Journal of Perinatology: neonatal and maternal-fetal medicine, 2015; 32(5):451-460|
|Publisher:||Thieme Medical Publishers|
|Jolande Y. Vis, Gert-Jan van Baaren, Femke F. Wilms, Martijn A. Oudijk, Anneke Kwee, Martina M. Porath, Hubertina C. Scheepers, Marc E. Spaanderman, Kitty W. Bloemenkamp, Jan M. van Lith, Antoinette C. Bolte, Caroline J. Bax, Jérôme Cornette, Johannes J. Duvekot, Sebastiaan W. Nij Bijvank, Jim van Eyck, Maureen T. Franssen, Krystyna M. Sollie, Mallory Woiski, Frank P. Vandenbussche, Joris A. van der Post, Patrick M. Bossuyt, Brent C. Opmeer, Ben W. Mol|
|Abstract:||OBJECTIVE: To evaluate whether tocolysis with nifedipine can be omitted in women with symptoms of preterm labor, a shortened cervix, and negative fetal fibronectin test. STUDY DESIGN: A randomized noninferiority trial was performed in all Dutch perinatal centers. Women with symptoms of preterm labor between 24 and 34 weeks, intact membranes, cervical length between 10 and 30 mm, and negative fibronectin test were randomly allocated to nifedipine (80 mg/day) or placebo. The primary outcome was delivery within 7 days. Secondary outcomes were severe neonatal morbidity and mortality. We also followed all eligible nonrandomized women. RESULTS: We allocated 37 women to nifedipine and 36 women to placebo. In the nifedipine group, three women (8.1%) delivered within 7 days, compared with one woman (2.8%) in the placebo group (difference -5.3%; one-sided 95% confidence limit 4.5%). Median gestational age at delivery were respectively 37 + 0 (interquartile range [IQR] 34 + 6 to 38 + 5) and 38 + 2 (IQR 37 + 0 to 39 + 6) weeks (p = 0.008). In the nifedipine group, three pregnancies (8.1%) had a poor outcome; there were no poor outcomes in the placebo group. We observed similar trends in eligible nonrandomized women. CONCLUSION: In symptomatic women with preterm labor, a shortened cervix, and negative fibronectin test, placebo treatment is not inferior to tocolysis with nifedipine.|
|Keywords:||Preterm labor; fetal fibronectin; cervical length; tocolysis; nifedipine|
|Rights:||Copyright © 2015, Rights Managed by Georg Thieme Verlag KG Stuttgart • New York|
|Appears in Collections:||Aurora harvest 7|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.